Cdc7-IN-8

Cdc7-IN-8

• CAS Number: 2606780-38-3
• UNSPSC Description: Cdc7-IN-8 is a potent inhibitor of Cdc7. Cdc7 is a serine/threonine kinase which activates MCM promotion by phosphorylating the microchromosome maintenance protein (MCM protein), an important element of the DNA replication initiator. Cdc7-IN-8 has the potential for the research of cancer diseases (extracted from patent WO2021032170A1, compound 1-1/1-2)[1].
• Target Antigen: CDK
• Type: Reference compound
• Related Pathways: Cell Cycle/DNA Damage
• Applications: Cancer-Kinase/protease
• Field of Research: Cancer
• Assay Protocol: https://www.medchemexpress.com/cdc7-in-8.html
• Solubility: 10 mM in DMSO
• Smiles: O=C1C2=C(C3=C(O2)C4=CNN=C4CCC3)N=C(N1)[C@@H]5CC6CCN5CC6
• Molecular Weight: 351.40
• References & Citations: [1]Lun Lu, et al. Tetracyclic compound used as cdc7 inhibitor. Patent WO2021032170A1.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported